Literature DB >> 21845542

Presence of L-kynurenine aminotransferase III in retinal ganglion cells and corpora amylacea in the human retina and optic nerve.

Robert Rejdak1, Carmen Rummelt, Eberhart Zrenner, Paweł Grieb, Konrad Rejdak, Etsuo Okuno, Sebastian Thaler, Katarzyna Nowomiejska, Friedrich Kruse, Waldemar Turski, Anselm Gm Junemann.   

Abstract

BACKGROUND: Corpora amylacea (CAm) are a hallmark of aging and neurodegeneration. The presence of kynurenine aminotransferases I and II (KAT I and II) in CAm in the human retina and optic nerve has been already shown. The present study aimed to examine kynurenine aminotransferase III (KAT III) immunoreactivity in CAm in the human retina and optic nerve.
MATERIAL AND METHODS: Polyclonal antibody against KAT III was used on sections of human eyes enucleated due to malignant uveal melanoma. PAS-stained sections of CAm were compared with KAT III stained ones.
RESULTS: KAT III immunoreactivity was observed in CAm in the retina, prelaminar, laminar and retrolaminar region of the optic nerve with similar location to PAS-stained sections. The most intense staining was observed in the retrolaminar part of the optic nerve. KAT III immunoreactivity was also present in the cytoplasm of retinal ganglion cells.
CONCLUSIONS: Expression of KAT III in CAm in the human retina and optic nerve indicates that this enzyme may be relevant in mechanisms of neurodegeneration leading to CAm formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845542

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  3 in total

1.  Reelin immunoreactivity in neuritic varicosities in the human hippocampal formation of non-demented subjects and Alzheimer's disease patients.

Authors:  Tina Notter; Irene Knuesel
Journal:  Acta Neuropathol Commun       Date:  2013-06-26       Impact factor: 7.801

2.  The presence of kynurenine aminotransferases in the human cornea: Evidence from bioinformatics analysis of gene expression and immunohistochemical staining.

Authors:  Anna Matysik-Woźniak; Anselm Jünemann; Waldemar A Turski; Artur Wnorowski; Krzysztof Jóźwiak; Roman Paduch; Etsuo Okuno; Joanna Moneta-Wielgoś; Tomasz Chorągiewicz; Ryszard Maciejewski; Robert Rejdak
Journal:  Mol Vis       Date:  2017-06-26       Impact factor: 2.367

3.  Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes.

Authors:  Michal Fiedorowicz; Tomasz Choragiewicz; Sebastian Thaler; Frank Schuettauf; Dominika Nowakowska; Kamila Wojtunik; Michele Reibaldi; Teresio Avitabile; Tomasz Kocki; Waldemar A Turski; Agnieszka Kaminska; Pawel Grieb; Eberhart Zrenner; Robert Rejdak; Mario Damiano Toro
Journal:  Front Physiol       Date:  2019-10-01       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.